Boldenone

CAS No. 846-48-0

Boldenone( —— )

Catalog No. M21343 CAS No. 846-48-0

Boldenone is an anabolic steroid developed for veterinary use.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 83 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Boldenone
  • Note
    Research use only, not for human use.
  • Brief Description
    Boldenone is an anabolic steroid developed for veterinary use.
  • Description
    Boldenone is an anabolic steroid developed for veterinary use.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    846-48-0
  • Formula Weight
    286.4
  • Molecular Formula
    C19H26O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:57 mg/mL (199.1 mM)
  • SMILES
    C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)C=C[C@]34C
  • Chemical Name
    (8R9S10R13S14S17S)-17-hydroxy-1013-dimethyl-67891011121314151617-dodecahydro-3H-cyclopenta[a]phenanthren-3-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Viljanto M J T Kicman A Walker C J et al. Elucidation of the Biosynthetic Pathways of Boldenone in the Equine Testis[J]. Steroids 2019.
molnova catalog
related products
  • Imperialine 3-β-D-gl...

    Imperialine 3-β-D-glucoside is a natural product. Imperialine 3-β-D-glucoside may exhibit anti-tumor properties against multi-drug resistant tumor cells.

  • Labetalone hydrochlo...

    Labetalone hydrochloride is an impurity of Labetalol. Labetalol is an orally active adrenoceptor blocking drug, Labetalol is a competitive antagonist at both alpha- and beta-adrenoceptor sites.

  • Emicizumab

    Emicizumab(ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A.